RxDoctor Payments Data

Karen Thomas, DO

Neurology · Virginia Beach, VANPI 1013091339

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Medtronic. That places this record below the midpoint for neurology clinicians in VA, where the typical reported total is $1,288.

$13in general payments, 2019–2025

Across 1 payment — averaging $12.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13
$509,307in research payments, 2019–2025

Across 45 payments — averaging $11,318 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$298K
  • UCB SA$94K
  • Sage Therapeutics, LLC$54K
  • Sunovion Pharmaceuticals Inc.$26K
  • AbbVie$23K
  • Roche TCRC, Inc.$12K
  • plus $2K from 1 others

What the payments were for

  • Food & beverage$13100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$13

How this compares

$13 in reported general payments places this provider in the 5th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$75,648
Medicare patients
335
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GocovriAmantadine Hcl11$37,720
RytaryCarbidopa/Levodopa12$23,147
Carbidopa-LevodopaCarbidopa/Levodopa363$15,303
Carbidopa-Levodopa ErCarbidopa/Levodopa83$9,794
Rasagiline Mesylate30$5,856
Entacapone13$3,596
Primidone69$3,151
AmantadineAmantadine Hcl44$2,730
Propranolol Hcl ErPropranolol Hcl32$1,750
Memantine Hcl57$1,710
Gabapentin85$1,667
Levetiracetam18$1,442
RivastigmineRivastigmine Tartrate16$1,090
Pramipexole DihydrochloridePramipexole Di-Hcl32$1,005
Venlafaxine Hcl ErVenlafaxine Hcl11$905

Paid to pharmacies, not to this prescriber.

Other neurology in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →